In this episode, we examine a pair of early-stage drug development stocks at the forefront of cancer research: Theralase Technologies (TSXV:TLT) and Oncolytics Biotech (NASDAQ:ONCY).
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
